CUFinder

Adam Dupuy

Adam Dupuy

University of Iowa

H-index: 38

North America-United States

Contact Adam Dupuy

About Adam Dupuy

Adam Dupuy, With an exceptional h-index of 38 and a recent h-index of 27 (since 2020), a distinguished researcher at University of Iowa, specializes in the field of Cancer, genetics, insertional mutagenesis.

His recent articles reflect a diverse array of research interests and contributions to the field:

ABCB1 promotes uveal melanoma cell resistance to FR900359 and identifies a tumor cell subpopulation with a distinct gene expression signature

Abstract A026: Identifying mechanisms to target in combination with trametinib to improve therapeutic efficacy in low-grade serous ovarian cancer

Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance

Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma

Identifying mechanisms of therapeutic resistance in low-grade serous ovarian cancer (2282)

Characterization of genetic mechanisms of ovarian tumor progression using sleeping beauty mutagenesis in vivo (2296)

Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer

Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?

Adam Dupuy Information

University

Position

___

Citations(all)

7050

Citations(since 2020)

2100

Cited By

5888

hIndex(all)

38

hIndex(since 2020)

27

i10Index(all)

58

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Adam Dupuy Skills & Research Interests

Cancer

genetics

insertional mutagenesis

Top articles of Adam Dupuy

ABCB1 promotes uveal melanoma cell resistance to FR900359 and identifies a tumor cell subpopulation with a distinct gene expression signature

Cancer Research

2024/3/22

Abstract A026: Identifying mechanisms to target in combination with trametinib to improve therapeutic efficacy in low-grade serous ovarian cancer

Cancer Research

2024/3/4

Jacob L Schillo
Jacob L Schillo

H-Index: 1

Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance

NAR cancer

2024/3/1

Jacob L Schillo
Jacob L Schillo

H-Index: 1

Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma

Iscience

2023/10/20

Jacob L Schillo
Jacob L Schillo

H-Index: 1

Identifying mechanisms of therapeutic resistance in low-grade serous ovarian cancer (2282)

Gynecologic oncology

2023/9/1

Jesse Riordan
Jesse Riordan

H-Index: 14

Adam Dupuy
Adam Dupuy

H-Index: 26

Characterization of genetic mechanisms of ovarian tumor progression using sleeping beauty mutagenesis in vivo (2296)

Gynecologic oncology

2023/9/1

Jesse Riordan
Jesse Riordan

H-Index: 14

Adam Dupuy
Adam Dupuy

H-Index: 26

Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer

Nature communications

2023/7/18

Zhe Jiang
Zhe Jiang

H-Index: 16

Amjad Ali
Amjad Ali

H-Index: 5

Marianne Koritzinsky
Marianne Koritzinsky

H-Index: 28

Adam Dupuy
Adam Dupuy

H-Index: 26

Eldad Zacksenhaus
Eldad Zacksenhaus

H-Index: 23

Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?

2023/5/1

Prajwal Dhakal
Prajwal Dhakal

H-Index: 9

Grerk Sutamtewagul
Grerk Sutamtewagul

H-Index: 6

Adam Dupuy
Adam Dupuy

H-Index: 26

Vijaya Raj Bhatt
Vijaya Raj Bhatt

H-Index: 25

Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer

Cancers

2022/10/6

Yiyang Li
Yiyang Li

H-Index: 13

Wei Zhou
Wei Zhou

H-Index: 2

Xiangbing Meng
Xiangbing Meng

H-Index: 15

Long Li
Long Li

H-Index: 3

Meng Wu
Meng Wu

H-Index: 1

Adam Dupuy
Adam Dupuy

H-Index: 26

Shujie Yang
Shujie Yang

H-Index: 12

In vivo functional genomics identifies essentiality of potassium homeostasis in medulloblastoma

bioRxiv

2022/7/23

Xin Wang
Xin Wang

H-Index: 6

Xian Wang
Xian Wang

H-Index: 25

Xin Chen
Xin Chen

H-Index: 14

Guanqiao Shan
Guanqiao Shan

H-Index: 5

Yi Xiong
Yi Xiong

H-Index: 3

Hamza Farooq
Hamza Farooq

H-Index: 2

Craig Daniels
Craig Daniels

H-Index: 18

Allan Bradley
Allan Bradley

H-Index: 75

Vijay Ramaswamy
Vijay Ramaswamy

H-Index: 52

Xuejun Li
Xuejun Li

H-Index: 18

Yu Sun
Yu Sun

H-Index: 8

Xi Huang
Xi Huang

H-Index: 8

Machine learning approach informs biology of cancer drug response

BMC bioinformatics

2022/5/17

Transposon Mutagenesis Reveals RBMS3 as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis

bioRxiv

2022/2/28

Adam Dupuy
Adam Dupuy

H-Index: 26

Annie Liu
Annie Liu

H-Index: 19

Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis

Cancer research

2022/11/15

Annie Liu
Annie Liu

H-Index: 19

SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas

NPJ precision oncology

2022/10/21

WDR26 and MTF2 are therapeutic targets in multiple myeloma

Journal of Hematology & Oncology

2021/12

Yan Cheng
Yan Cheng

H-Index: 14

Adam Dupuy
Adam Dupuy

H-Index: 26

Jing Dong
Jing Dong

H-Index: 20

Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer

Nature communications

2021/9/2

Wei Wang
Wei Wang

H-Index: 14

Rotem Karni
Rotem Karni

H-Index: 25

Eldad Zacksenhaus
Eldad Zacksenhaus

H-Index: 23

Jüri Reimand
Jüri Reimand

H-Index: 34

Abstract B08: Identification and characterization of Rho family GTPases as drivers of drug resistance in BRAFV600 mutant melanoma

Cancer Research

2020/10/1

Jacob L Schillo
Jacob L Schillo

H-Index: 1

Abstract B01: Genome-scale shRNA screen provides insight into the role of CUL3 in adaptive mechanisms of resistance to mutant BRAF inhibition

Cancer Research

2020/10/1

Lei Zhao
Lei Zhao

H-Index: 9

Christopher Stipp
Christopher Stipp

H-Index: 21

Adam Dupuy
Adam Dupuy

H-Index: 26

Michael Henry
Michael Henry

H-Index: 27

Abstract PR17: Sleeping Beauty mutagenesis reveals a Src-dependent DBL GEF family signaling mechanism driving MAPK inhibitor resistance in BRAF mutant melanoma

Cancer Research

2020/10/1

A genetic screen to identify gain-and loss-of-function modifications that enhance T-cell infiltration into tumors

Cancer immunology research

2020/9/1

George J Weiner
George J Weiner

H-Index: 39

See List of Professors in Adam Dupuy University(University of Iowa)